# Molecular Diagnosis of Heart Allograft Rejection Using Intra-Graft Targeted Gene Expression Profiling.

> **NCT06436027** · — · COMPLETED · sponsor: **Paris Translational Research Center for Organ Transplantation** · enrollment: 496 (actual)

## Conditions studied

- Heart Transplant Rejection

## Interventions

- **DIAGNOSTIC_TEST:** Nano-Heart tool: Intra-Graft Targeted Gene Expression Profiling

## Key facts

- **NCT ID:** NCT06436027
- **Lead sponsor:** Paris Translational Research Center for Organ Transplantation
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-10
- **Primary completion:** 2023-12-15
- **Final completion:** 2023-12-15
- **Target enrollment:** 496 (ACTUAL)
- **Last updated:** 2024-05-30

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06436027

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06436027, "Molecular Diagnosis of Heart Allograft Rejection Using Intra-Graft Targeted Gene Expression Profiling.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06436027. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*